Research Team Turns to Nanotechnology for Chemical Reaction Promoters The new approach could mean cheaper catalysts which could help create sustainable energy sources.
The Invisible Line of Cyberdefense Ranked among the top 30 universities in the nation for cybersecurity programs, UCF’s pipeline of talent and research into the “good side” of the cyber world has never been more important than it is at this moment.
Genes Responsible for Protecting Frogs May Play Role in Death from Global Disease UCF and Smithsonian researchers have made a breakthrough in the fight against the leading cause of amphibian deaths worldwide.
UCF 1st in Florida, 6th Nationally for Coveted National Science Foundation CAREER Grants The university saw a record 12 recipients — representing some of the brightest early-career STEM professionals in the nation —this year, thanks to an initiative led by UCF’s previous CAREER recipients.
A New Way to Move: Exercising During COVID-19 Tom Fisher, kinesiology senior lecturer and exercise physiology expert, provides some suggestions for staying motivated and active during the pandemic.
UCF Installs Vending Machines Stocked with Face Coverings Each student, faculty and staff member is allotted one free washable cloth mask, which can be obtained through a vending machine or at one of the university’s distribution sites.
Knight Line Student-Run Calling Center Focuses on Caring Since the pandemic hit, UCF students who typically fundraise for the university through alumni outreach are now connecting with grads through “care calls.”
UCF Earns International Accreditation in Healthcare Simulation Education UCF’s nursing simulation program is among more than 100 programs in 10 countries to receive accreditation from the Society for Simulation in Healthcare, which is the world’s largest healthcare simulation accrediting body.
Cancer-fighting Technology Developed at UCF Licensed to French Pharmaceutical Giant College of Medicine Associate Professor Alicja Copik’s nanoparticle technology that helps stimulate natural cancer-killing cells is now in the hands of Sanofi, which hopes to find new blood-cancer treatments.